Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Recommended Testing for Legionnaires' Disease Misses Cases

By LabMedica International staff writers
Posted on 18 Oct 2011
The guidelines concerning testing patients for possible community-acquired pneumonia due to Legionella may underestimate the number of cases being seen by clinicians.

These guidelines recommend testing for the urine antigen of Legionella in patients with any of the following: severe pneumonia requiring intensive care unit admission, failure of outpatient antibiotics, active alcohol abuse, history of travel within previous two weeks, or pleural effusion.

Doctors at the Rhode Island Hospital (Providence, RI, USA) carried out a retrospective study that identified nearly 4,000 patients with a primary or secondary diagnosis of pneumonia in an 18-month period. More...
Of these, 1,406 patients (35%) had a Legionella urine antigen test and/or Legionella culture as follows: 1,251 had a urine antigen test alone; 49 had a Legionella culture alone; and 106 had both a Legionella culture and urine antigen test. During the same time period, 626 patients underwent bronchoscopy and had bronchoscopic specimens sent to the microbiology laboratory for culture, 277 (44%) of whom had Legionella testing done as follows: 122 had a Legionella culture alone; 31 had a urine antigen test alone; and 124 had both a Legionella culture and urine antigen test.

The study found that if testing was only done in patients felt to be at increased risk of Legionnaires' disease based on the current guidelines, more than 40% of Legionella cases could be missed based on this single-center study. Nearly all of the cases were community-acquired and all cases were L. pneumophila serogroup 1. Thirty-six of the 37 cases were diagnosed solely by urine antigen testing. This suggests that cases of Legionnaires' disease due to other serogroups may have been missed because Legionella culture was underutilized. The scientists suggest more widespread testing for Legionella in patients admitted to hospitals with pneumonia.

Leonard Mermel, DO, medical director of the epidemiology and infection control department at Rhode Island Hospital, said," This single-center study suggests that current recommendations for Legionella testing will result in missed cases. More widespread testing will identify additional cases allowing focused antimicrobial therapy and will alert public health officials of such Legionella cases.” The study was published on September 7, 2011, in the Biomedcentral's online journal BMC Infectious Diseases.

Related Links:
Rhode Island Hospital



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.